BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis
NASDAQ:BWAY - US10501L1061 - ADR
15.85 USD
-0.12 (-0.75%)
BWAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. BWAY has an excellent financial health rating, but there are some minor concerns on its profitability. BWAY is growing strongly while it also seems undervalued. This is an interesting combination These ratings would make BWAY suitable for value and growth investing!
1. Profitability
1.1 Basic Checks
BWAY had positive earnings in the past year.
BWAY had a positive operating cash flow in the past year.
BWAY had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of BWAY (3.91%) is better than 80.00% of its industry peers.
With a decent Return On Equity value of 6.14%, BWAY is doing good in the industry, outperforming 78.95% of the companies in the same industry.
BWAY has a better Return On Invested Capital (1.90%) than 69.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.91% | ||
| ROE | 6.14% | ||
| ROIC | 1.9% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 9.01%, BWAY belongs to the best of the industry, outperforming 81.58% of the companies in the same industry.
The Operating Margin of BWAY (4.32%) is better than 68.95% of its industry peers.
With an excellent Gross Margin value of 74.51%, BWAY belongs to the best of the industry, outperforming 86.84% of the companies in the same industry.
BWAY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.32% | ||
| PM (TTM) | 9.01% | ||
| GM | 74.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BWAY is destroying value.
BWAY has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BWAY has more shares outstanding
Compared to 1 year ago, BWAY has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.95 indicates that BWAY is not in any danger for bankruptcy at the moment.
BWAY has a Altman-Z score of 4.95. This is in the better half of the industry: BWAY outperforms 80.00% of its industry peers.
BWAY has a debt to FCF ratio of 0.69. This is a very positive value and a sign of high solvency as it would only need 0.69 years to pay back of all of its debts.
BWAY has a better Debt to FCF ratio (0.69) than 92.11% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that BWAY is not too dependend on debt financing.
BWAY has a better Debt to Equity ratio (0.07) than 64.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.69 | ||
| Altman-Z | 4.95 |
ROIC/WACC0.22
WACC8.77%
2.3 Liquidity
BWAY has a Current Ratio of 5.03. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.03, BWAY is in the better half of the industry, outperforming 76.32% of the companies in the same industry.
A Quick Ratio of 4.75 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a Quick ratio of 4.75. This is in the better half of the industry: BWAY outperforms 79.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.75 |
3. Growth
3.1 Past
BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1178.38%, which is quite impressive.
Looking at the last year, BWAY shows a very strong growth in Revenue. The Revenue has grown by 29.04%.
The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)1178.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.89%
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%21.26%
3.2 Future
The Earnings Per Share is expected to grow by 54.94% on average over the next years. This is a very strong growth
BWAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.57% yearly.
EPS Next Y58.83%
EPS Next 2Y52.73%
EPS Next 3Y54.94%
EPS Next 5YN/A
Revenue Next Year16.02%
Revenue Next 2Y18.84%
Revenue Next 3Y19.57%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.40, which indicates a very decent valuation of BWAY.
BWAY's Price/Earnings ratio is rather cheap when compared to the industry. BWAY is cheaper than 92.63% of the companies in the same industry.
BWAY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.06.
BWAY is valuated cheaply with a Price/Forward Earnings ratio of 7.84.
Based on the Price/Forward Earnings ratio, BWAY is valued cheaply inside the industry as 97.37% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, BWAY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.4 | ||
| Fwd PE | 7.84 |
4.2 Price Multiples
64.74% of the companies in the same industry are more expensive than BWAY, based on the Enterprise Value to EBITDA ratio.
BWAY's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BWAY is cheaper than 77.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.4 | ||
| EV/EBITDA | 62.73 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BWAY's earnings are expected to grow with 54.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y52.73%
EPS Next 3Y54.94%
5. Dividend
5.1 Amount
BWAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BWAY (9/5/2025, 8:00:53 PM)
15.85
-0.12 (-0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.19%
Inst Owner Change-3.74%
Ins Owners16.69%
Ins Owner ChangeN/A
Market Cap299.59M
Analysts85.71
Price Target0.1 (-99.37%)
Short Float %0.42%
Short Ratio0.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)35.29%
Min EPS beat(2)-22.64%
Max EPS beat(2)93.23%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)0.01%
Revenue beat(4)3
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.82%
Revenue beat(8)6
Avg Revenue beat(8)1.7%
Revenue beat(12)6
Avg Revenue beat(12)-23.98%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.82%
PT rev (3m)23.13%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)0.54%
EPS NY rev (1m)20.25%
EPS NY rev (3m)20.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.53%
Revenue NY rev (3m)-2.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.4 | ||
| Fwd PE | 7.84 | ||
| P/S | 6.89 | ||
| P/FCF | 37.4 | ||
| P/OCF | 24.7 | ||
| P/B | 4.7 | ||
| P/tB | 4.7 | ||
| EV/EBITDA | 62.73 |
EPS(TTM)1.39
EY8.77%
EPS(NY)2.02
Fwd EY12.76%
FCF(TTM)0.42
FCFY2.67%
OCF(TTM)0.64
OCFY4.05%
SpS2.3
BVpS3.37
TBVpS3.37
PEG (NY)0.19
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.91% | ||
| ROE | 6.14% | ||
| ROCE | 2.25% | ||
| ROIC | 1.9% | ||
| ROICexc | 13.5% | ||
| ROICexgc | 13.5% | ||
| OM | 4.32% | ||
| PM (TTM) | 9.01% | ||
| GM | 74.51% | ||
| FCFM | 18.43% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.69 | ||
| Debt/EBITDA | 1.28 | ||
| Cap/Depr | 223.14% | ||
| Cap/Sales | 9.47% | ||
| Interest Coverage | 8.86 | ||
| Cash Conversion | 325.76% | ||
| Profit Quality | 204.52% | ||
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.75 | ||
| Altman-Z | 4.95 |
F-Score6
WACC8.77%
ROIC/WACC0.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1178.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.89%
EPS Next Y58.83%
EPS Next 2Y52.73%
EPS Next 3Y54.94%
EPS Next 5YN/A
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%21.26%
Revenue Next Year16.02%
Revenue Next 2Y18.84%
Revenue Next 3Y19.57%
Revenue Next 5YN/A
EBIT growth 1Y256.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y217.63%
OCF growth 3Y127.03%
OCF growth 5YN/A